| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
8 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-03-02 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencing Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized
Medical University of South Carolina
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_,
today announced that it has begun selling CompuFlo® / CathCheck™ disposables to the
Medical University of South Carolina _MUSC_. The MUSC University Medical Center is
a nationally recognized and leading health sciences university, recently ranked as
the number one hospital in South Carolina. MUSC Health owns and operates eight hospitals
and provides patient care throughout the state of South Carolina.
The Board of Directors of the Issuer appreciates the support of Dr. Hebbar, Director
Obstetrics Anesthesia, and her team at MUSC. This latest commercial order follows
extensive testing on the part of the MUSC team. This decision by another leading U.S.
medical center further illustrates the favorable response to both CathCheck and CompuFlo
as the Company executes on its goal to become the new standard of care in epidural
procedures.
The clinical and safety benefits of the CompuFlo Epidural / CathCheck System are backed
by extensive published clinical data demonstrating significant reductions in epidural
punctures, as well as complication rates, and contributes to savings of time on the
part of anesthesiologists. Moreover, the CompuFlo instrument has the potential to
significantly reduce costs associated with morbidity, providing a direct economic
benefit to healthcare institutions. Similarly, the CathCheck technology has the potential
to transform the monitoring of catheter placement following an epidural procedure
by confirming the placement of a catheter within 2 minutes, versus 20-40 minutes using
conventional methods.
Founded in 1824, the Medical University of South Carolina _MUSC_ continues the tradition
of excellence in education, research and patient care. MUSC educates and trains more
than 3,000 students and nearly 800 residents in six colleges and has more than 17,000
employees. As the state’s only integrated academic health sciences center and largest
non-federal employer in Charleston, the university and its affiliates have collective
annual budgets in excess of $3.2 billion, with an annual economic impact of nearly
$4 billion and annual research funding in excess of $284 million.
As the clinical health system of the Medical University of South Carolina, MUSC Health
is dedicated to delivering the highest quality patient care available, while training
generations of competent, compassionate health care providers to serve the people
of South Carolina and beyond. Comprising some 1,600 beds, more than 100 outreach sites,
the MUSC College of Medicine, the physicians’ practice plan, and nearly 275 telehealth
locations, MUSC Health owns and operates eight hospitals situated in Charleston, Chester,
Florence, Lancaster and Marion counties. In 2020, for the sixth consecutive year,
U.S. News & World Report named MUSC Health the No. 1 hospital in South Carolina.
|
|
|
RB_ASO: Commencing Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized
Medical University of South Carolina 
